Author:
Talwar K. K.,Bhagwati Mohit M.,Yaduvanshi Amitabh
Publisher
Springer Nature Singapore
Reference33 articles.
1. Ahmad AF, Dwivedi G, O’Gara F, Caparros-Martin J, Ward NC (2019) The gut microbiome and cardiovascular disease: current knowledge and clinical potential. Am J Physiol Heart Circ Physiol 317(5):H923–H938
2. Angelakis E, Raoult D (2018) Gut microbiota modifications and weight gain in early life. Hum Microbiome J 7–8:10–14
3. Bennett BJ, de Aguiar Vallim TQ, Wang Z, Shih DM, Meng Y, Gregory J et al (2013) Trimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulation. Cell Metab 17(1):49–60
4. Cardiovascular Diseases (CVDs) (2017, May 17) World Health Organisation. https://www.who.int/en/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds). Accessed online
5. Chen K, Zheng X, Feng M, Li D, Zhang H (2017) Gut microbiota-dependent metabolite trimethylamine N-oxide contributes to cardiac dysfunction in Western diet-induced obese mice. Front Physiol 8:139